<PAGE>
Exhibit 23
CONSENT OF INDEPENDENT AUDITORS
The Board of Directors
Pharmacopeia Inc.:
We consent to the inclusion of our report dated September 22, 2000, with
respect to the combined balance sheets of the Oxford Molecular Group plc's
software division as of December 31, 1998 and 1999 and the related combined
profit and loss account, movement on shareholders' funds, and cash flows for
each of the years in the three-year period ended December 31, 1999, which
report appears in the Form 8-K/A of Pharmacopeia Inc. dated November 13, 2000.
/s/ KPMG LLP
Portland, Oregon
November 13, 2000
